Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 426,361 | 238,361 | 237,910 | 210,247 | 209,100 |
| Receivables | 811,198 | 837,275 | 779,265 | 729,740 | 692,388 |
| Inventories | 917,982 | 822,250 | 829,458 | 933,214 | 958,233 |
| TOTAL | $2,641,125 | $2,357,719 | $2,351,296 | $2,378,077 | $2,304,585 |
| Non-Current Assets | |||||
| PPE Net | 560,211 | 548,025 | 539,743 | 551,734 | 533,985 |
| Intangibles | 3,364,630 | 3,327,959 | 3,337,017 | 3,390,032 | 3,375,420 |
| Other Non-Current Assets | 656,451 | 638,691 | 586,506 | 585,245 | 526,796 |
| TOTAL | $4,581,292 | $4,514,675 | $4,463,266 | $4,527,011 | $4,436,201 |
| Total Assets | $7,222,417 | $6,872,394 | $6,814,562 | $6,905,088 | $6,740,786 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 249,278 | 237,728 | 177,445 | 202,395 | 177,048 |
| Accrued Expenses | 365,749 | 377,678 | 356,076 | 332,136 | 348,263 |
| TOTAL | $904,079 | $910,655 | $773,030 | $764,073 | $770,802 |
| Non-Current Liabilities | |||||
| Long Term Debt | 667,578 | 697,313 | 997,047 | 1,216,769 | 1,351,511 |
| Deferred Revenues | 157,188 | 152,554 | 150,753 | 148,897 | 146,718 |
| aiOther Non-Current Liabilities | 227,760 | 183,701 | 196,020 | 225,700 | 158,933 |
| TOTAL | $1,123,312 | $1,097,696 | $1,411,612 | $1,659,161 | $1,719,608 |
| Total Liabilities | $2,027,391 | $2,008,351 | $2,184,642 | $2,423,234 | $2,490,410 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 146,796 | 146,932 | 146,907 | 147,089 | 147,092 |
| Common Shares | 758 | 588 | 588 | 588 | 588 |
| Retained earnings | 5,225,111 | 4,991,647 | 4,769,963 | 4,539,963 | 4,401,841 |
| Other shareholders' equity | -132,427 | -251,796 | -265,569 | -208,615 | -320,404 |
| TOTAL | $5,195,026 | $4,864,043 | $4,629,920 | $4,481,854 | $4,250,376 |
| Total Liabilities And Equity | $7,222,417 | $6,872,394 | $6,814,562 | $6,905,088 | $6,740,786 |